Superoxide dismutase induces differentiation of Friend erythroleukemia cells

J Cell Physiol. 1989 May;139(2):370-6. doi: 10.1002/jcp.1041390220.

Abstract

Friend erythroleukemia cells (FELC) served as a model system for cell differentiation because these cells can be triggered to differentiate by a variety of chemical agents. Treatment with the classical inducer of differentiation, hexamethylene bisacetamide (HMBA), stimulated superoxide dismutase (SOD) activity, which increased in parallel with HMBA-induced differentiation. Furthermore, FELC were shown to differentiate in response to the addition of liposomes containing SOD. Oxidative treatment with liposomes containing D-amino acid oxidase or xanthine oxidase, cumene peroxide, or potassium superoxide also induced differentiation, whereas antioxidants such as alpha-tocopherol, butylated hydroxytoluene, or beta-carotene did not induce differentiation. Also, HMBA induction of differentiation was suppressed by treatment with antioxidants.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetamides / pharmacology
  • Antioxidants / pharmacology
  • Cell Differentiation / drug effects*
  • Liposomes / pharmacology
  • Oxidation-Reduction / drug effects
  • Superoxide Dismutase / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Acetamides
  • Antioxidants
  • Liposomes
  • Superoxide Dismutase
  • hexamethylene bisacetamide